The Venture Codex Logo

The Venture Codex

Surterra Wellness

55 Ivan Allen Blvd Ste 900, Atlanta, GA, 30308, United States

Overview

Surterra Wellness offers a wide variety of medical, health and wellness products in multiple delivery options, including vaporizer pens, tinctures, oral sprays, topical creams, time-released transdermal patches, and soft gels. Its brand portfolio includes Surterra Wellness, Florida's Finest, The Apothecary Shoppe, and Coral Reefer. The company operates vertically in Florida, Texas, Nevada and Massachusetts. Founded in 2014 by CEO William "Beau" Wrigley, Jr., Surterra has raised over $300M in private capital to date. The company intends to use new capital to fund strategic acquisitions and infrastructure capital expenditures. Surterra is based in Atlanta, GA. Surterra Wellness, based in Atlanta, is a medical cannabis company that offers a wide variety of products across multiple delivery options including vaporizer pens, tinctures, oral sprays, topical creams, time‑released transdermal patches and soon‑to‑be‑launched softgels. Led by CEO Jake Bergmann, the company operates 10 Wellness Centers across Florida and holds one of 14 vertically integrated medical marijuana licenses in Florida and one of three in Texas. Surterra supports state‑wide, next‑day delivery in Florida via three distribution centers and reports over 300,000 square feet of cultivation space. The company says its current footprint covers 49 million Americans in two of the nation’s fastest‑growing state populations. Surterra plans to use its recent funding to construct substantial cultivation space in Florida, execute partnerships with premier consumer brands, accelerate product development, and expand into new state markets. It also intends to conduct clinical research trials on cannabinoid treatments for anxiety, pain, PTSD and other significant health issues.

Total raised
$165M
Funding rounds
2
Latest round
Series D
Latest activity
Jun 2019

Industries

  • Cannabis
  • E-Commerce
  • Health Care
  • Medical
  • Wellness
Visit website

Recent funding

  1. Series D

    Jun 2019

    $100M

  2. Series C

    Aug 2018

    $65M

Team

  • Joseph Dorn

    Medical Director

    LinkedIn
  • Shanon Robison

    General Manager

    LinkedIn
  • Marisa Hutchinson

    General Manager

    LinkedIn
  • Jervonne Singletary

    Director of Government and Regulatory Affairs

    LinkedIn